AbbVie - 4 Year Dividend History | ABBV

Historical dividend payout and yield for AbbVie (ABBV) since 2015. The current TTM dividend payout for AbbVie (ABBV) as of July 19, 2019 is $4.28. The current dividend yield for AbbVie as of July 19, 2019 is 6.24%.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $101.325B $32.753B
AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie aims to help patients' live healthier lives and collaborate on sustainable healthcare solutions.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $345.980B 14.98
Pfizer (PFE) United States $237.798B 13.89
Roche Holding AG (RHHBY) Switzerland $229.876B 0.00
Novartis AG (NVS) Switzerland $214.654B 18.45
Merck (MRK) United States $209.550B 18.05
Novo Nordisk (NVO) Denmark $117.569B 19.51
Sanofi (SNY) France $104.721B 12.91
Eli Lilly (LLY) United States $103.675B 19.24
AstraZeneca (AZN) United Kingdom $101.620B 11.70
GlaxoSmithKline (GSK) United Kingdom $101.605B 12.88
Bristol-Myers Squibb (BMY) United States $70.875B 10.47
Bayer (BAYRY) Germany $62.440B 9.10
H Lundbeck (HLUYY) Denmark $7.558B 10.91